Trump Orders Boost to US Drug Manufacturing | JQJO

President Trump signed an executive order aiming to boost domestic pharmaceutical manufacturing. The order directs the FDA to streamline approvals for US plants, increase fees for foreign facilities, and improve enforcement of ingredient sourcing. The EPA will accelerate construction of drug manufacturing facilities. The goal is to reduce reliance on foreign drug production, bolster national security, and lower drug costs.